Loading...
Infant Bacterial Therapeutics AB (IFTBF, $5.47) was a top loser over the last three months, falling -3 to $5.47 per share. A.I.dvisor analyzed 745 stocks in the Biotechnology Industry for the 3-month period ending January 8, 2026, and found that of them (4) exhibited an Uptrend while of them (5) demonstrated a Downtrend.
Industry Biotechnology